Wave Life Sciences Ltd.
- CIK: 0001631574
- EIN: 00-0000000
- Business address: 7 STRAITS VIEW, #12-00, MARINA ONE EAST TOWER, SINGAPORE, Singapore, 018936
About Wave Life Sciences Ltd.
Wave Life Sciences Ltd. (CIK: 0001631574) is an American company incorporated in the state of Singapore. Head office is located at 7 STRAITS VIEW, #12-00, MARINA ONE EAST TOWER, SINGAPORE, Singapore, 018936. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Wave Life Sciences Ltd. is a public company and trade via Over-The-Counter (OTC).Old names:
- Wave Life Sciences Pte Ltd from 2015-02-Feb to 2015-02-Nov
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| GSK PLC | 0001131399 | Jan-23-2023 | 10 percent owner |
| RA Capital Healthcare Fund LP | 0001315082 | Apr-01-2021 | 10 percent owner |
| RA CAPITAL MANAGEMENT, L.P. | 0001346824 | Apr-01-2021 | director, 10 percent owner |
| Shah Rajeev M. | 0001619841 | Apr-01-2021 | 10 percent owner |
| Tan Aik Na | 0001821285 | Aug-18-2020 | director |
| Gaiero David G | 0001799784 | Jan-09-2020 | officer: Interim CFO |
| CORRIGAN MARK | 0001250661 | Sep-04-2019 | director |
| Wagner Heidi L | 0001655029 | Sep-04-2019 | director |
| Pott Amy | 0001787363 | Sep-04-2019 | director |
| Baldry Mark | 0001644137 | Aug-05-2019 | officer: Chief Commerical Officer |
| Kolchinsky Peter | 0001384859 | Aug-10-2017 | director, 10 percent owner |
| Rawcliffe Adrian | 0001555851 | Feb-01-2017 | director |
| HENRY CHRISTIAN O | 0001263805 | Nov-10-2016 | director |
| Regnante Keith | 0001682068 | Aug-16-2016 | officer: Chief Financial Officer |
| Panzara Michael A. | 0001679039 | Jul-11-2016 | officer: Franchise Lead, Neurology |
| GUERCIOLINI ROBERTO | 0001286837 | Nov-10-2015 | officer: See Remarks |
| Verdine Gregory L. | 0001572315 | Nov-10-2015 | director |
| Vargeese Chandra | 0001657675 | Nov-10-2015 | officer: See Remarks |
| Francis Chris | 0001657709 | Nov-10-2015 | officer: See Remarks |
| BOLNO PAUL | 0001657710 | Nov-10-2015 | director, officer: See Remarks |
| Moran Kyle | 0001657765 | Nov-10-2015 | officer: See Remarks |
| Miura Koji | 0001657766 | Nov-10-2015 | director |
| Wada Takeshi | 0001657767 | Nov-10-2015 | director |
| TAKANASHI KEN | 0001657768 | Nov-10-2015 | director, 10 percent owner |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership | 0001657769 | Nov-10-2015 | 10 percent owner |
| Shin Nippon Biomedical Laboratories, Ltd. | 0001657770 | Nov-10-2015 | 10 percent owner |
| Tanaka Masaharu | 0001657771 | Nov-10-2015 | director, 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Wave Life Sciences Ltd.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-131691 ( Act) Size: 0 KB |
Nov-27-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-009108 (33 Act) Size: 0 KB |
Nov-25-2024 | 241496979 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-262067 (34 Act) Size: KB |
Nov-20-2024 | 241478119 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-127740 ( Act) Size: 0 KB |
Nov-15-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-008615 (33 Act) Size: 0 KB |
Nov-15-2024 | 241468099 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-126622 ( Act) Size: 0 KB |
Nov-13-2024 | |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-24-006436 (34 Act) Size: KB |
Nov-12-2024 | 241448913 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-24-006408 (34 Act) Size: KB |
Nov-12-2024 | 241444229 |
| S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-255192 (33 Act) Size: KB |
Nov-12-2024 | 241443596 |
| S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-255187 (33 Act) Size: KB |
Nov-12-2024 | 241443535 |
| S-3ASR | Document | Automatic shelf registration statement of securities of well-known seasoned issuers Acc-no: 0001193125-24-255180 (33 Act) Size: KB |
Nov-12-2024 | 241443470 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-124595 (34 Act) Size: KB |
Nov-12-2024 | 241443360 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-255157 (34 Act) Size: KB |
Nov-12-2024 | 241443344 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-008284 (33 Act) Size: 0 KB |
Nov-08-2024 | 241440740 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0002012383-24-003590 (34 Act) Size: KB |
Nov-08-2024 | 241439735 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-247660 (34 Act) Size: KB |
Oct-30-2024 | 241411431 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-115726 ( Act) Size: 0 KB |
Oct-18-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-115725 ( Act) Size: 0 KB |
Oct-18-2024 | |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0002012383-24-000564 (34 Act) Size: KB |
Oct-18-2024 | 241380521 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-007765 (33 Act) Size: 0 KB |
Oct-16-2024 | 241374845 |
Recent 20 filings. View all Wave Life Sciences Ltd. filings
Reviews
Catherine
Thanks I look forward to using the product to improve my skin tone
Pelisari
young lad who new his job ansered questions and new what was best for me.
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Frequently Asked Questions
Tags:
- Wave Life Sciences Ltd. overview
- Wave Life Sciences Ltd. job
- Wave Life Sciences Ltd. stock
- Wave Life Sciences Ltd. ownership
- Wave Life Sciences Ltd. CEO
- Wave Life Sciences Ltd. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 